Personal information

Keywords

toxicology, adverse reactions, pharmacovigilance

Countries

Colombia

Activities

Collapse all

Employment (5)

Clinica del Country: Bogota, CO

2021-05 to present | Clinical Toxicologist (Bogotá)
Employment
Source: Self-asserted source
Luis Carlos Rojas-Rodríguez

Universidad Militar Nueva Granada: Bogota, CO

2020-08-03 to present | Simulation lab instructor (Bogotá)
Employment
Source: Self-asserted source
Luis Carlos Rojas-Rodríguez

CLINICOS IPS: Bogotá D.C, Cundinamarca, CO

2019-06 to present | Clinical Toxicologist
Employment
Source: Self-asserted source
Luis Carlos Rojas-Rodríguez

Universidad del Rosario: Bogotá, CO

2018-08-01 to present | Pharmacology teacher (Bogotá)
Employment
Source: Self-asserted source
Luis Carlos Rojas-Rodríguez

Clínica Nuestra Señora de la Paz: Bogotá, Bogotá, CO

2019-06 to 2020-05 | Clinical Toxicologist
Employment
Source: Self-asserted source
Luis Carlos Rojas-Rodríguez

Education and qualifications (2)

Universidad del Rosario: Bogotá, Bogotá, CO

2018-09-18 | Clinical Toxicologist
Education
Source: Self-asserted source
Luis Carlos Rojas-Rodríguez

Universidad del Rosario: Bogotá, Bogotá, CO

2017-12-17 | Physician
Education
Source: Self-asserted source
Luis Carlos Rojas-Rodríguez

Professional activities (2)

Asociación de Toxicología Clínica Colombiana: Bogotá, Colombia, CO

2020 to present | Membership
Membership
Source: Self-asserted source
Luis Carlos Rojas-Rodríguez

Asociación Colombiana de Farmacovigilancia: Bogotá, CO

2020 to present | Member
Membership
Source: Self-asserted source
Luis Carlos Rojas-Rodríguez

Works (7)

The Inappropriate Use of GLP-1 Analogs: Reflections from Pharmacoepidemiology

Pharmacoepidemiology
2024-11-20 | Journal article
DOI: 10.3390/pharma3040025
Contributors: Sofía Echeverry-Guerrero; Salomé González-Vélez; Ana-Sofía Arévalo-Lara; Juan-Camilo Calvache-Orozco; Sebastián Kurt Villarroel-Hagemann; Luis Carlos Rojas-Rodríguez; Andrés M. Pérez-Acosta; Carlos-Alberto Calderon-Ospina
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Molecular, Pathophysiological, and Clinical Aspects of Corticosteroid-Induced Neuropsychiatric Effects: From Bench to Bedside

Biomedicines
2024-09-19 | Journal article
DOI: 10.3390/biomedicines12092131
Contributors: Sara Sofía-Avendaño-Lopez; Angela Johanna Rodríguez-Marín; Mateo Lara-Castillo; Juanita Agresott-Carrillo; Luna Estefanía Lara-Cortés; Juan Felipe Sánchez-Almanzar; Sophya Villamil-Cruz; Luis Carlos Rojas-Rodríguez; Daniel Felipe Ariza-Salamanca; Mariana Gaviria-Carrillo et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Making Sense of Composite Endpoints in Clinical Research

Journal of Clinical Medicine
2023-06-29 | Journal article
DOI: 10.3390/jcm12134371
Contributors: Daniela Baracaldo-Santamaría; John Edwin Feliciano-Alfonso; Raul Ramirez-Grueso; Luis Carlos Rojas-Rodríguez; Camilo Alberto Dominguez-Dominguez; Carlos Alberto Calderon-Ospina
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Fósforo Blanco

Intoxicaciones en la práctica clínica
2022 | Book chapter | Writing - original draft
Contributors: Luis Carlos Rojas-Rodríguez
Source: Self-asserted source
Luis Carlos Rojas-Rodríguez

Synthetic Pharmacotherapy for Systemic Lupus Erythematosus: Potential Mechanisms of Action, Efficacy, and Safety

Medicina
2022-12-27 | Journal article
DOI: 10.3390/medicina59010056
Part of ISSN: 1648-9144
Contributors: Angélica María Téllez Arévalo; Abraham Quaye; Luis Carlos Rojas-Rodríguez; Brian Poole; Daniela Baracaldo-Santamaría; Claudia M. Tellez Freitas
Source: Self-asserted source
Luis Carlos Rojas-Rodríguez
grade
Preferred source (of 2)‎

Therapeutic Drug Monitoring of Antifungal Agents in Critically Ill Patients: Is There a Need for Dose Optimisation?

Antibiotics
2022-05-12 | Journal article
DOI: 10.3390/antibiotics11050645
Part of ISSN: 2079-6382
Contributors: Daniela Baracaldo-Santamaría; Juan Cala-Garcia; Germán José Medina-Rincón; Luis Carlos Rojas-Rodriguez; Carlos-Alberto Calderon-Ospina
Source: Self-asserted source
Luis Carlos Rojas-Rodríguez

Drug safety of frequently used drugs and substances for self-medication in COVID-19

Therapeutic Advances in Drug Safety
2022-01 | Journal article
DOI: 10.1177/20420986221094141
Contributors: Daniela Baracaldo-Santamaría; Santiago Pabón-Londoño; Luis Carlos Rojas-Rodriguez
Source: check_circle
Crossref
How many people are using ORCID?